regadenoson



regadenoson


SMILES CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1
InChIKey LZPZPHGJDAGEJZ-AKAIJSEGSA-N

Chemical Properties

Hydrogen bond acceptors 12
Hydrogen bond donors 5
Rotatable bonds 4
Molecular weight (Da) 390.1


No bioactivity data available.

regadenoson


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.